Novel BiIO 4 /BiVO 4 heterojunction was successfully constructed for the first time. It exhibits significantly enhanced photocatalytic activity for degradation of RhB and photocurrent generation.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: